A detailed history of Israel Englander (Millennium Management LLC) transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Millennium Management LLC holds 357,632 shares of HCM stock, worth $6.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
357,632
Previous 357,593 0.01%
Holding current value
$6.42 Million
Previous $6.01 Million 1.91%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$16.36 - $21.78 $638 - $849
39 Added 0.01%
357,632 $6.12 Million
Q1 2024

May 15, 2024

SELL
$12.08 - $18.56 $413,897 - $635,921
-34,263 Reduced 8.74%
357,593 $6.01 Million
Q4 2023

Feb 14, 2024

SELL
$16.25 - $20.23 $7.13 Million - $8.87 Million
-438,507 Reduced 52.81%
391,856 $7.1 Million
Q2 2023

Aug 14, 2023

SELL
$10.78 - $17.73 $841,303 - $1.38 Million
-78,043 Reduced 8.59%
830,363 $9.96 Million
Q1 2023

May 15, 2023

BUY
$13.02 - $19.87 $499,759 - $762,690
38,384 Added 4.41%
908,406 $11.8 Million
Q4 2022

Feb 14, 2023

BUY
$7.65 - $15.51 $3.89 Million - $7.89 Million
508,959 Added 140.96%
870,022 $12.9 Million
Q3 2022

Nov 14, 2022

BUY
$8.63 - $15.52 $2.68 Million - $4.82 Million
310,502 Added 614.11%
361,063 $3.2 Million
Q2 2022

Aug 15, 2022

SELL
$8.59 - $20.77 $507,265 - $1.23 Million
-59,053 Reduced 53.87%
50,561 $639,000
Q1 2022

May 16, 2022

BUY
$15.52 - $35.65 $1.7 Million - $3.91 Million
109,614 New
109,614 $2.07 Million
Q4 2021

Feb 14, 2022

SELL
$28.89 - $35.33 $3.13 Million - $3.83 Million
-108,463 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$35.66 - $42.94 $6.36 Million - $7.65 Million
-178,227 Reduced 62.17%
108,463 $3.97 Million
Q2 2021

Aug 16, 2021

BUY
$23.7 - $39.27 $5.68 Million - $9.41 Million
239,538 Added 508.01%
286,690 $11.3 Million
Q1 2021

May 17, 2021

BUY
$27.01 - $36.8 $388,916 - $529,883
14,399 Added 43.96%
47,152 $1.33 Million
Q4 2020

Feb 16, 2021

BUY
$27.51 - $34.36 $108,829 - $135,928
3,956 Added 13.74%
32,753 $1.05 Million
Q3 2020

Nov 16, 2020

SELL
$25.8 - $34.61 $357,897 - $480,109
-13,872 Reduced 32.51%
28,797 $930,000
Q2 2020

Aug 14, 2020

BUY
$17.65 - $28.05 $753,107 - $1.2 Million
42,669 New
42,669 $1.18 Million
Q1 2020

May 14, 2020

SELL
$15.19 - $29.51 $730,532 - $1.42 Million
-48,093 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$17.17 - $25.95 $340,927 - $515,263
19,856 Added 70.32%
48,093 $1.21 Million
Q3 2019

Nov 14, 2019

SELL
$17.84 - $22.69 $423,664 - $538,842
-23,748 Reduced 45.68%
28,237 $503,000
Q2 2019

Aug 15, 2019

SELL
$22.0 - $31.78 $5.46 Million - $7.88 Million
-248,015 Reduced 82.67%
51,985 $1.14 Million
Q2 2019

Aug 14, 2019

BUY
$22.0 - $31.78 $5.29 Million - $7.65 Million
240,593 Added 404.99%
300,000 $3.03 Million
Q1 2019

May 14, 2019

BUY
$21.27 - $30.58 $1.26 Million - $1.82 Million
59,407 New
59,407 $1.82 Million
Q4 2018

Feb 14, 2019

SELL
$23.09 - $37.69 $4.92 Million - $8.04 Million
-213,285 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$26.55 - $34.38 $4.95 Million - $6.4 Million
186,281 Added 689.83%
213,285 $6.87 Million
Q2 2018

Aug 14, 2018

SELL
$27.79 - $34.49 $198,003 - $245,741
-7,125 Reduced 20.88%
27,004 $814,000
Q1 2018

May 15, 2018

BUY
$28.87 - $41.13 $985,304 - $1.4 Million
34,129 New
34,129 $1.01 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.1B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.